Heart Failure Clinical Trial
— TTRinHFpEFOfficial title:
Prevalence and Prediction of Transthyretin Amyloidosis in Ambulatory Patients With Heart Failure With Preserved Ejection Fraction
Recent studies have shown that transthyretin amyloidosis (ATTR) can sometimes cause a type of heart failure where the pumping function of the heart is normal, also known as Heart Failure with Preserved Ejection Fraction (HFpEF) or diastolic heart failure. In this single center diagnostic study, we will evaluate for ATTR in patients with HFpEF in order to to determine how frequently this occurs and how we can predict which heart failure patients may have TTR amyloidosis. Our goal is to identify amyloidosis in heart failure patients earlier so that they can start treatment.
Status | Recruiting |
Enrollment | 515 |
Est. completion date | December 31, 2024 |
Est. primary completion date | June 30, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 65 Years and older |
Eligibility | Inclusion Criteria: - Patients with a confirmed diagnosis of HFpEF. - Age =65 years old Exclusion Criteria: - End stage chronic kidney disease on dialysis (CKD stage 5 as defined as eGFR <15mL/min) - no history of HFrEF (LVEF<40%) with the exception of low LVEF in the setting of acute decompensation, AF RVR, ACS/MI, etc - Negative 99mTc-pyrophosphate scan within a year - Unable to lie down for 15 minutes for the 99mTc-pyrophosphate scan - Known diagnosis of amyloidosis - Severe valvular heart disease that is uncorrected (moderate to severe is considered exclusionary) |
Country | Name | City | State |
---|---|---|---|
United States | Massachusetts General Hospital | Boston | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Massachusetts General Hospital | Akcea Therapeutics, Alnylam Pharmaceuticals, Eidos Therapeutics, a BridgeBio company, Pfizer |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Presence of autonomic neuropathy | Medical records and phone follow-up with patients and/or their physicians will allow the investigators to ascertain vital status and any significant clinical events | Time from study Visit until the date of documented event up to 5 years after the study closure | |
Other | Presence of carpal tunnel syndrome | Medical records and phone follow-up with patients and/or their physicians will allow the investigators to ascertain vital status and any significant clinical events | Time from study Visit until the date of documented event up to 5 years after the study closure | |
Other | Presence of polyneuropathy | Medical records and phone follow-up with patients and/or their physicians will allow the investigators to ascertain vital status and any significant clinical events | Time from study Visit until the date of documented event up to 5 years after the study closure | |
Other | Combined endpoint of days alive outside of hospital from HF hospitalizations at one and five years | Medical records and phone follow-up with patients and/or their physicians will allow the investigators to ascertain vital status and any significant clinical events | Time from study Visit until the date of documented event up to 5 years after the study closure | |
Other | Individual endpoints of all-cause mortality, cardiovascular mortality, all-cause hospitalizations, cardiovascular hospitalizations and HF hospitalizations. | Medical records and phone follow-up with patients and/or their physicians will allow the investigators to ascertain vital status and any significant clinical events | Time from study Visit until the date of documented event up to 5 years after the study closure | |
Primary | Diagnosis of 99mTc-pyrophosphate scan positive ATTR | A cardiac disease in which misfolded proteins aggregate into amyloid fibril and deposit interstitially, leading to diastolic dysfunction and heart failure | Day 1 (day of study visit) | |
Secondary | New York Heart Association function classification | Classifies the severity of a patients Heart Failure in terms of their limitations during physical activity | Day 1 (day of study visit) | |
Secondary | Impact of HF as assessed by Kansas City Cardiomyopathy Questionnaire | Kansas City Cardiomyopathy Questionnaire is a questionnaire that determines in the impact of Heart Failure on their health status, such as quality of life, symptoms, function, etc.) | Day 1 (day of study visit) | |
Secondary | Exercise capacity as determined by a 6-minute walk test | The 6 minute walk test is used to determine an objective measurement of a patients aerobic capacity and endurance | Day 1 (day of study visit) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Active, not recruiting |
NCT05896904 -
Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction
|
N/A | |
Completed |
NCT05077293 -
Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
|
||
Recruiting |
NCT05631275 -
The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
|
||
Enrolling by invitation |
NCT05564572 -
Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology
|
N/A | |
Enrolling by invitation |
NCT05009706 -
Self-care in Older Frail Persons With Heart Failure Intervention
|
N/A | |
Recruiting |
NCT04177199 -
What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
|
||
Terminated |
NCT03615469 -
Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY)
|
N/A | |
Recruiting |
NCT06340048 -
Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure
|
Phase 1/Phase 2 | |
Recruiting |
NCT05679713 -
Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
|
||
Completed |
NCT04254328 -
The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure
|
N/A | |
Completed |
NCT03549169 -
Decision Making for the Management the Symptoms in Adults of Heart Failure
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Enrolling by invitation |
NCT05538611 -
Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
|
||
Recruiting |
NCT04262830 -
Cancer Therapy Effects on the Heart
|
||
Completed |
NCT06026683 -
Conduction System Stimulation to Avoid Left Ventricle Dysfunction
|
N/A | |
Withdrawn |
NCT03091998 -
Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support
|
Phase 1 | |
Recruiting |
NCT05564689 -
Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy
|